Predicting Acute Kidney Injury in Trauma Patients: Biomarkers as Early Indicators
Jazyk angličtina Země Spojené státy americké Médium electronic
Typ dokumentu pozorovací studie, časopisecké články
PubMed
38204152
PubMed Central
PMC10795410
DOI
10.12659/msm.942271
PII: 942271
Knihovny.cz E-zdroje
- MeSH
- akutní poškození ledvin * diagnóza etiologie MeSH
- biologické markery MeSH
- dospělí MeSH
- kreatinin MeSH
- kreatinkinasa MeSH
- lidé MeSH
- lipokalin-2 MeSH
- myoglobin * MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- Názvy látek
- biologické markery MeSH
- kreatinin MeSH
- kreatinkinasa MeSH
- lipokalin-2 MeSH
- myoglobin * MeSH
BACKGROUND Acute kidney injury (AKI) is a common cause of organ failure in patients after major trauma and is associated with increased morbidity and mortality. Early identification of patients at risk enables the implementation of a bundle of supportive care, which reduces the incidence of AKI. The primary objective of our study was to investigate whether the levels of biomarkers on admission predicted the onset of early AKI in patients with serious injuries. MATERIAL AND METHODS This prospective observational study included 98 adult patients of both sexes with a serious injury (injury severity score >16). At admission, blood samples were taken, and creatinine, neutrophil gelatinase-associated lipocalin (NGAL), high mobility group box 1 (HMGB-1), and markers of rhabdomyolysis (creatine kinase, myoglobin) were evaluated. The patients were provided with standard resuscitation care, and the occurrence of AKI was monitored during the first 7 days after admission to the Intensive Care Unit, according to the Kidney Disease Improving Global Outcomes diagnostic criteria. RESULTS AKI occurred in 25 (25.5%) patients, in whom the admission levels of HMGB-1, NGAL, creatinine, and myoglobin were significantly higher than in non-AKI patients (48.3±98.4 vs 113.0±209.4 µg/L, P=0.006; 150.2±349.9 vs 181.4±152.2 µg/L, P=0.004; 83.1±20.8 vs 118.8±32.2 µmol/L, P<0.005; 2734.4±2214.5 vs 4182.3±2477.1 µg/L, P=0.008, respectively). Creatine kinase was 14.5±9.2 µkat/L in non-AKI patients and 13.7±7.9 µkat/L in AKI patients (P=0.916). CONCLUSIONS Admission levels of HMGB-1, NGAL, creatinine, and myoglobin predicted the risk of AKI in severely injured patients.
Zobrazit více v PubMed
Perkins ZB, Captur G, Bird R, et al. Trauma induced acute kidney injury. PLoS One. 2019;14(1):e0211001. PubMed PMC
Harrois A, Libert N, Duranteau J. Acute kidney injury in trauma patients. Curr Opin Crit Care. 2017;23(6):447–56. PubMed
Bihorac A, Delano MJ, Schold JD, et al. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg. 2010;252(1):158–65. PubMed PMC
Søvik S, Isachsen MS, Nordhuus KM, et al. Acute kidney injury in trauma patients admitted to the ICU: A systematic review and meta-analysis. Intensive Care Med. 2019;45(4):407–19. PubMed
Harrois A, Soyer B, Gauss T, et al. Traumabase® Group. Prevalence and risk factors for acute kidney injury among trauma patients: A multicenter cohort study. Crit Care. 2018;22(1):344. PubMed PMC
Cohen MJ, Brohi K, Calfee CS, et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: Role of injury severity and tissue hypoperfusion. Crit Care. 2009;13(6):R174. PubMed PMC
Vourc’h M, Roquilly A, Asehnoune K. Trauma-induced damage-associated molecular patterns-mediated remote organ injury and immunosuppression in the acutely ill patient. Front Immunol. 2018;9:1330. PubMed PMC
Devarajan P. NGAL in acute kidney injury: from serendipity to utility. Am J Kidney Dis. 2008;52(3):395–99. PubMed
Cruz DN, de Cal M, Garzotto F, et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. 2010;36(3):444–51. PubMed PMC
Makris K, Spanou L. Acute kidney injury: Definition, pathophysiology and clinical phenotypes. Clin Biochem Rev. 2016;37(2):85–98. PubMed PMC
Tarazona V, Figueiredo S, Hamada S, et al. Admission serum myoglobin and the development of acute kidney injury after major trauma. Ann Intensive Care. 2021;11(1):140. PubMed PMC
Baker SP, O’Neill B, Haddon W, Jr, Long WB. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187–96. PubMed
Katz N, Ronco C. Acute kidney stress – a useful term based on evolution in the understanding of acute kidney injury. Crit Care. 2016;20:23. PubMed PMC
Makris K, Markou N, Evodia E, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med. 2009;47(1):79–82. PubMed
Li N, Zhao WG, Xu FL, et al. Neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in patients with traumatic brain injury. J Nephrol. 2013;26(6):1083–88. PubMed
El-Abdellati E, Eyselbergs M, Sirimsi H, et al. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Ann Intensive Care. 2013;3(1):8. PubMed PMC
Byerly S, Benjamin E, Biswas S, et al. Peak creatinine kinase level is a key adjunct in the evaluation of critically ill trauma patients. Am J Surg. 2017;214(2):201–6. PubMed
Raju NA, Rao SV, Joel JC, et al. Predictive value of serum myoglobin and creatine phosphokinase for development of acute kidney injury in traumatic rhabdomyolysis. Indian J Crit Care Med. 2017;21(12):852–56. PubMed PMC
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl. 2017;7:1–59. Erratum in: Kidney Int Suppl. 2017;7(3):e1. PubMed PMC
Meersch M, Volmering S, Zarbock A. Prevention of acute kidney injury. Best Pract Res Clin Anaesthesiol. 2017;31(3):361–70. PubMed